Data companies band together to form RWE Alliance
Can an industry coalition help craft policy to support the use of Real-World Evidence? Five prominent real-world data and analytics companies are betting on it, launching the RWE Alliance.
AI in healthcare: From data gaps to data democratization
In the panel "The Data Problem in Scaling Artificial Intelligence in Healthcare" at the recent MedCity CONVERGE conference, experts from big pharma and health tech discussed challenges in scaling AI such as data gaps and navigating the potential ethical pitfalls of democratizing data.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
What are the opportunities for AI in healthcare and what Big Data challenges lie ahead?
In a panel discussion at the MedCity CONVERGE conference exploring the opportunities and challenges posed by the data underpinning AI tools, panelists representing big pharma, health tech and clinical data network shared some of their insights.
What’s health tech’s evolving role in cancer treatment? Learn more at the CONVERGE conference in Philadelphia!
Health tech applications in the realm of cancer treatment will be a major theme of the CONVERGE conference in Philadelphia June 19 in Philadelphia, from improving the patient experience to AI. Register now!
Flatiron, Foundation Medicine study points to real-world data’s utility in oncology
Data published in JAMA on lung cancer patients treated with immunotherapy drugs, gleaned from EHRs and genomic sequencing, backs up clinical trial data and validates clinico-genomic database, the companies said.
Who has the chops to succeed Scott Gottlieb as FDA commissioner?
Gottlieb, who is expected to step down in about a month, leaves behind a unique legacy and will likely be difficult to replace.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
FDA and Flatiron Health expand cancer data research alliance
The collaboration, which started back in 2016, has focused on how real-world evidence derived from EHRs can support regulatory decision-making.
Foundation Medicine appoints new CEO; exec provides forecasts for precision medicine in 2019
With the approval of Loxo's Vitrakvi, pan-cancer drugs and an emphasis on real-world data are likely to become important trends trends this year.
FDA hires Flatiron Health CMO as principal deputy commissioner
Oncologist Amy Abernethy, who currently serves as Flatiron's chief medical officer, chief scientific officer and senior vice president of oncology, will join the agency in the next few months.
Big data and big pharma giants join forces on cancer research effort
Merck and Palantir Technologies are forming a joint research venture called Syntropy as a way to offer data analytics tools to healthcare organizations.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Roche will acquire Flatiron Health for $1.9B
Pharmaceutical giant Roche will buy New York City-based startup Flatiron Health. The Swiss company led Flatiron's $175 million Series C round. The deal is expected to close in the first half of this year.
These 10 companies received 38% of digital health investment funding in 2016
In a new analysis, Accenture dives deeper into digital health funding. The assessment includes a prediction that annual investment in digital health startups will reach $7 billion by the end of 2017.
This is why pre-design research is essential for the IVD industry
Which in vitro diagnostics are filling providers’ needs? Are they deficient in a performance characteristic that your IVD will improve upon or have you developed a new method that is more cost-efficient?
Can Flatiron Health redeem EHRs?
EHRs don't always get the most love from providers. But with its OncoEMR, New York City-based startup Flatiron Health is rethinking the concept of an EHR and everything it encompasses.
Why is clinical research so messed up and how can it be fixed?
The panel discussion at the Association of Community Cancer Centers highlighted some of the inherent challenges in doing clinical trials and ways to work towards overcoming them.